These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E Lupus; 2007; 16(12):929-38. PubMed ID: 18042586 [TBL] [Abstract][Full Text] [Related]
8. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Lopez LR; Simpson DF; Hurley BL; Matsuura E Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973 [TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis. Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I Lupus; 2006; 15(2):80-6. PubMed ID: 16539278 [TBL] [Abstract][Full Text] [Related]
10. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome. Kajiwara T; Yasuda T; Matsuura E J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950 [TBL] [Abstract][Full Text] [Related]
11. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. Kobayashi K; Matsuura E; Liu Q; Furukawa J; Kaihara K; Inagaki J; Atsumi T; Sakairi N; Yasuda T; Voelker DR; Koike T J Lipid Res; 2001 May; 42(5):697-709. PubMed ID: 11352976 [TBL] [Abstract][Full Text] [Related]
12. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen. Kobayashi K; Kishi M; Atsumi T; Bertolaccini ML; Makino H; Sakairi N; Yamamoto I; Yasuda T; Khamashta MA; Hughes GR; Koike T; Voelker DR; Matsuura E J Lipid Res; 2003 Apr; 44(4):716-26. PubMed ID: 12562869 [TBL] [Abstract][Full Text] [Related]
13. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis? Matsuura E; Lopez LR Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445 [TBL] [Abstract][Full Text] [Related]
14. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y Lupus; 2005; 14(9):736-41. PubMed ID: 16218478 [TBL] [Abstract][Full Text] [Related]
16. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome. Kobayashi K; Lopez LR; Matsuura E Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014 [TBL] [Abstract][Full Text] [Related]
17. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis. Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986 [TBL] [Abstract][Full Text] [Related]
18. [OxLDL/β2-glycoprotein I complex as a pro-atherogenic autoantigen. Is atherosclerosis an autoimmune disease?]. Kraml P Vnitr Lek; 2016; 62(11 Suppl 4):S48-51. PubMed ID: 27921425 [TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048 [TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome. Matsuura E; Kobayashi K; Koike T; Shoenfeld Y; Khamashta MA; Hughes GR Lupus; 2003; 12(7):550-4. PubMed ID: 12892397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]